Outsourcing in Drug Discovery, 9th Edition

    Published: May 8, 2020 | Price: $5,500.00 – $11,000.00

    Outsourcing drug discovery is the beginning phase of the drug development process. Through outsourcing portions of their drug discovery programs, many pharmaceutical and biotechnology companies have found an effective cost-cutting strategy that can also improve the hit-to-lead conversion and early identification of unsuccessful compounds. In view of the fact that outsourcing can accelerate the drug discovery process, the business of contract drug discovery has evolved from providing low-end research services to more value-added high-end research. Outsourcing in Drug Discovery provides...
    Cell Therapy and Gene Therapy Markets

    Published: April 27, 2020 | Price: $5,500.00 – $11,000.00

    What is the Size of the Cell and Gene Therapy Market? According to the latest report on the cell and gene therapy market from Kalorama Information, the global market for cell and gene therapy in 2020 is estimated to reach $3,866 million And most of the market is for the treatment of cancer. Dermatological, Cardiovascular – Blood, Oncology, Ophthalmic, Musculoskeletal and other conditions. With the COVID-19 crisis, there are some efforts to adapt this promising technology to the treatment and...
    Vaccine Development and Production Trends, COVID-19 and Other Vaccines Pipeline

    Published: April 21, 2020 | Price: $4,000.00 – $8,000.00

    The vaccine market is poised for a rather substantial increase in the next five years due to the number of vaccines in development and the push for a COVID-19 vaccine. As the COVID-19 outbreak advanced worldwide, companies stepped up to the challenge, scrambling to provide a potential vaccine. In addition to discussion of COVID-19 vaccine development as it stands currently, this report examines the market for human vaccines used to prevent various types of disease, focusing on commercialized vaccines and...
    COVID-19 Clinical Lab Tracker

    Published: July 21, 2020 | Price: Original price was: $7,500.00.Current price is: $4,000.00.

    Trended bi-weekly data from March 26 to June 15th, and monthly from July to December. New purchasers will receive all historical data from March to December. Click here to download a brochure and sample data. This clinical diagnostics COVID-19 lab impacts tracker is produced through a continuous survey of clinical lab professionals at hundreds of locations around the United States. This is an interactive Tableau data deliverable with custom filtered views by key demographics, and can be viewed by using...
    Kalorama COVID-19 Update: Molecular Diagnostics, Immunoassays, Vaccines, Telehealth and Other Areas

    Published: April 7, 2020 | Price: $750.00 – $1,000.00

    For years, Kalorama Information has covered the fields of molecular diagnostics, immunoassays, vaccines and telehealth. These all find themselves both sought-after and challenged during the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the Kalorama analysis team on the fast-breaking events in the COVID-19 epidemic. Particular sections address the most important market changes: Molecular Diagnostics: It's important to note that the entire molecular testing concept originated in the midst of a crisis, at that time...
    Artificial Intelligence Markets in IVD

    Published: April 7, 2020 | Price: $4,000.00 – $8,000.00

    The past few years has seen extraordinary advances in artificial intelligence (AI) in clinical medicine. More products have been cleared for clinical use, more new research-use-only applications have come to market and many more are in development. In recent years, diagnostics companies – in collaboration with AI companies – have begun implementing increasingly sophisticated machine learning techniques to improve the power of data analysis for patient care. The goal is to use developed algorithms to standardize and aid interpretation of...
    The Worldwide Market for Point-of-Care (POC) Diagnostics, 7th Edition (Infectious Disease Testing, Cancer Point of Care, Rapid Coagulation, Urine Testing, Lipids, Pregnancy, Glucose and Other Tests)

    Published: March 17, 2020 | Price: $5,500.00 – $11,000.00

    This report represents the 7th edition of a fast-growing and competitive category of the in vitro diagnostic market. Point-of-care (POC) tests are diagnostics performed outside the central laboratory or executed via decentralized testing. POC testing has skyrocketed in the last 20 years as demand for accurate and fast testing has grown both inside and outside the hospital setting. The increasing introduction of transportable, portable, and handheld instruments has resulted in the migration of POC testing from the hospital environment to...
    The Market and Future Potential for Molecular Point of Care

    Published: March 11, 2020 | Price: $4,000.00 – $8,000.00

    THIS REPORT HAS A NEWER VERSION AVAILABLE: https://kaloramainformation.com/product/2021-molecular-point-of-care/   This report provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings. Major IVD companies such as Abbott and Roche compete in this segment, influenza competitors Sekisui and Quidel also operate, as do specialty concerns such as Curetis, Biocartis, and a host of small but innovative players. Molecular point of care or...
    Molecular Cancer Diagnostics Market

    Published: February 12, 2020 | Price: $5,500.00 – $11,000.00

    The potential of molecular diagnostic tools was initially recognized by onco-hematologists during the 1980s based on the observation that specific chromosomal translocations may significantly aid the diagnosis of various types of leukemia and lymphoma. Later, the emergence of user-friendly molecular methods such as PCR has opened up practical applications that helped multiple approaches for cancer diagnosis and treatments. DNA sequencing is increasingly employed in cancer molecular diagnostics. PCR is the initial step used in isolating and amplifying specific regions of...
    Worldwide Wound Care Market Summary

    Published: January 30, 2020 | Price: $3,500.00 – $7,000.00

    Wound care is very much a challenge for both patients and healthcare providers. The wound care market is a technologically enriched environment dedicated to advancing wound care therapies. Kalorama Information's report, Worldwide Wound Care Market Summary, identifies market opportunity for major sectors of this important market. A particular focus is given to biotechnology used in wound care, including advanced biodressings and negative pressure wound systems. Market data in the report include: World Market Total Worldwide Wound Care Market Revenues 2019-2024...
    Clinical Laboratory Services Market, 5th Edition

    Published: January 27, 2020 | Price: $4,750.00 – $9,500.00

    Clinical laboratories are an essential part of the health industry. The market for laboratory services ranges from routine blood work to esoteric laboratory-developed tests (LDTs). In addition to diagnosing patients, clinical lab testing may be performed to evaluate disease progression, to monitor drug treatment and conditions, and to determine individual therapy. Kalorama’s Clinical Laboratory Services Market, 5th Edition, examines the world and regional markets and is essential for laboratory and IVD companies seeking to better understand the market potential. The...
    NASH Drug Pipeline and Market Overview

    Published: January 6, 2020 | Price: $2,000.00 – $4,000.00

    Non-alcoholic steatohepatitis (NASH) is a type of non-alcoholic fatty liver disease (NAFLD). NASH is characterized by inflammation in the liver and liver cell damage, which can lead to scarring of the liver (cirrhosis). No medications have been approved specifically for NASH but there are numerous products in development. NASH Drug Pipeline and Market Overview looks at the almost 80 drug candidates for the treatment of this disease in terms of developer, type of drug, phase study, and market entrance estimate....
    CAR-T Cell Therapy Market Review

    Published: December 19, 2019 | Price: $4,000.00 – $8,000.00

    CAR-T cell therapy is a form of immunotherapy that utilizes the body’s own T cells to target and destroy cancer cells. This therapy is a personalized form of treatment, meaning that each patient receives T cells that are geared specifically toward his or her cancer diagnosis. T-cell therapy works by removing existing T cells from a patient and having them grown and modified in a lab. These new T cells are given a gene for a specialized receptor, known as...
    Exome Sequencing Market

    Published: November 25, 2019 | Price: $4,000.00 – $8,000.00

    The increasing popularity of next-generation systems has fueled systems and sequencers, but the cost of sequencing – despite price declines – has led to demands for more efficient methods. Exome Sequencing is a widely used NGS technique that sequences all the exons in a genome. Rather than sequencing the entire human genome, only pieces of an individual's DNA that provide instructions for making proteins are sequenced. These pieces, called exons, are thought to make up roughly 2 percent of a...
    Blockchain Technologies in Healthcare

    Published: November 22, 2019 | Price: $2,000.00 – $4,000.00

    Blockchain is essentially a tool that has the potential to keep secure data in a distributed ledger with the capability to be shared across networks. The concept behind blockchain is that it has three components: a widely distributed network a shared ledger with validated access identities digital transactions Blockchain technology is emerging in many other industries but it has some unique challenges in healthcare. Blockchain Technologies in Healthcare discusses some of the major application areas for blockchain technology in healthcare:...